Insulet (PODD) Research & Development (2010 - 2026)

Insulet's Research & Development history runs 17 years deep, the most recent figure standing at $89.7 million for Q1 2026.

• Quarterly Research & Development rose 50.5% year-over-year to $89.7 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $331.2 million (up 44.63% YoY) and the FY2025 annual result came in at $301.1 million, up 37.11% from the prior year.
• Research & Development was $89.7 million for Q1 2026 at Insulet, down from $90.9 million in the prior quarter.
• Across five years, Research & Development topped out at $90.9 million in Q4 2025 and bottomed at $42.0 million in Q4 2023.
• A 5-year average of $58.6 million and a median of $54.9 million in 2024 frame the typical range for Research & Development.
• Annual changes were most pronounced in 2022 — Research & Development tumbled 61.7% — and 2026, when it surged 50.5%.
• Insulet's Research & Development stood at $49.5 million in 2022, then retreated by 15.15% to $42.0 million in 2023, then jumped by 44.29% to $60.6 million in 2024, then soared by 50.0% to $90.9 million in 2025, then retreated by 1.32% to $89.7 million in 2026.
• Business Quant data shows PODD's Research & Development at $89.7 million in Q1 2026, $90.9 million in Q4 2025, and $77.2 million in Q3 2025.